article thumbnail

World Pneumonia Day 2024: New Treatments and Innovations

XTalks

Pneumonia is a lung infection that can be caused by viruses, bacteria or fungi and can result in millions of hospitalizations and deaths annually. These antibiotics target bacteria through mechanisms distinct from traditional antibiotics, thus helping to reduce the impact of resistant strains.

Bacteria 110
article thumbnail

Good Gut Bacteria Can Aid in Healing Intestines Damaged by IBD

XTalks

A study published in Nature on July 30, 2020 states that good bacteria living in our gut can do much more than just help digest food and boost our immune system. According to studies conducted by researchers at Cincinnati Children’s Hospital, the bacteria can help heal damaged intestinal tissues.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Key Trends in the Life Sciences to Look Forward to in 2022

XTalks

If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the life sciences. Here is a look at some life science trends to expect in the coming year, including key themes and topics in the pharmaceutical, biotechnology and medical device industries to keep an eye out for in 2022.

article thumbnail

Singapore scientists discover ‘future-proof’ method using bacteria to remove phosphorus from wastewater

Scienmag

Credit: NTU Singapore Singapore Centre for Environmental Life […].

article thumbnail

2021 Year in Review: Leveraging New Technologies to Drive Innovation in the Life Sciences

XTalks

Xtalks is taking a look at some of the major stories and innovations of the year in the life sciences, many of which were driven by new, emerging and improved technologies. The year 2021 was all about continuing innovations in the life sciences. Life Science Innovations: Malaria and Influenza Vaccines.

article thumbnail

Governments and pharma relationships and implications for antimicrobial resistance

Pharmaceutical Technology

Before the Covid-19 pandemic, government-led investment and engagement in life sciences was relatively restricted worldwide, with the industry mostly funded via private investment. AMR occurs when disease-causing bacteria become resistant or immune to the antibiotics used to treat them.

article thumbnail

Vedanta Biosciences raises funds to advance defined bacterial consortia therapies

Pharmaceutical Technology

Co-led by new investors the AMR Action Fund and AXA IM Alts, the investment syndicate also included existing investors Reimagined Ventures, the Bill & Melinda Gates Foundation, Atlantic Neptune, Fiscus Ventures, PEAK6 and Skyviews Life Science.

Bacteria 130